Posted by Defense World Staff on Apr 28th, 2025
Russell Investments Group Ltd. boosted its position in Cinemark Holdings, Inc. (NYSE:CNK – Free Report) by 402.4% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,030 shares of the company’s stock after buying an additional 825 shares during the quarter. Russell Investments Group Ltd.’s holdings in Cinemark were worth $32,000 at the end of the most recent quarter.
Several other large investors also recently modified their holdings of CNK. R Squared Ltd bought a new position in shares of Cinemark during the fourth quarter valued at approximately $63,000. GAMMA Investing LLC grew its stake in Cinemark by 44.9% during the 4th quarter. GAMMA Investing LLC now owns 2,926 shares of the company’s stock worth $91,000 after buying an additional 906 shares during the last quarter. Smartleaf Asset Management LLC increased its position in Cinemark by 198.3% in the fourth quarter. Smartleaf Asset Management LLC now owns 3,320 shares of the company’s stock worth $103,000 after buying an additional 2,207 shares during the period. New Age Alpha Advisors LLC bought a new stake in Cinemark in the fourth quarter valued at $183,000. Finally, HighTower Advisors LLC acquired a new position in shares of Cinemark during the fourth quarter valued at $224,000.
Wall Street Analyst Weigh In
Several research analysts have commented on the stock. Macquarie restated an “outperform” rating and issued a $35.00 target price on shares of Cinemark in a research report on Thursday, February 20th. JPMorgan Chase & Co. upgraded Cinemark from a “neutral” rating to an “overweight” rating and raised their target price for the company from $30.00 to $34.00 in a research report on Friday, April 11th. Barrington Research reissued an “outperform” rating and issued a $40.00 price target on shares of Cinemark in a research note on Wednesday, February 19th. Wedbush restated a “neutral” rating and set a $32.00 price objective on shares of Cinemark in a research note on Tuesday, February 18th. Finally, Wells Fargo & Company reduced their price objective on shares of Cinemark from $38.00 to $36.00 and set an “overweight” rating for the company in a report on Wednesday, January 29th. One investment analyst has rated the stock with a sell rating, three have given a hold rating, seven have issued a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $33.10.
Check Out Our Latest Stock Analysis on Cinemark
Insider Transactions at Cinemark
In related news, insider Wanda Marie Gierhart sold 9,119 shares of the firm’s stock in a transaction on Tuesday, February 25th. The shares were sold at an average price of $27.00, for a total value of $246,213.00. Following the completion of the transaction, the insider now owns 147,414 shares of the company’s stock, valued at approximately $3,980,178. This trade represents a 5.83 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. 2.30% of the stock is owned by insiders.
Cinemark Price Performance
Cinemark stock opened at $29.51 on Monday. The business’s 50-day simple moving average is $26.15 and its 200 day simple moving average is $29.30. The company has a quick ratio of 0.96, a current ratio of 1.01 and a debt-to-equity ratio of 3.28. The stock has a market cap of $3.48 billion, a price-to-earnings ratio of 14.54 and a beta of 2.07. Cinemark Holdings, Inc. has a 12-month low of $16.32 and a 12-month high of $36.28.
Cinemark (NYSE:CNK – Get Free Report) last posted its quarterly earnings results on Wednesday, February 19th. The company reported $0.33 earnings per share for the quarter, missing analysts’ consensus estimates of $0.39 by ($0.06). The company had revenue of $814.30 million during the quarter, compared to analyst estimates of $797.18 million. Cinemark had a net margin of 10.16% and a return on equity of 65.83%. The business’s revenue for the quarter was up 27.5% compared to the same quarter last year. During the same period last year, the company earned ($0.15) EPS. As a group, research analysts anticipate that Cinemark Holdings, Inc. will post 1.93 earnings per share for the current year.
Cinemark Announces Dividend
The business also recently declared a — dividend, which was paid on Wednesday, March 19th. Stockholders of record on Wednesday, March 5th were issued a $0.08 dividend. The ex-dividend date was Wednesday, March 5th. Cinemark’s dividend payout ratio (DPR) is presently 15.76%.
Cinemark Company Profile
Cinemark Holdings, Inc, together with its subsidiaries, engages in the motion picture exhibition business. As of February 16, 2024, it operated 501 theatres with 5,719 screens in 42 states and 13 countries in South and Central America. Cinemark Holdings, Inc was founded in 1984 and is headquartered in Plano, Texas.
Read More
- Five stocks we like better than Cinemark
- Growth Stocks: What They Are, Examples and How to Invest
- Texas Instruments: Earnings Beat, Upbeat Guidance Fuel Recovery
- How to Choose Top Rated Stocks
- O’Reilly Automotive: An Anytime Buy for Buy-and-Hold Investors
- Breakout Stocks: What They Are and How to Identify Them
- Chipotle Mexican Grill Serves Smoking Hot Entry Point in Q2
Want to see what other hedge funds are holding CNK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cinemark Holdings, Inc. (NYSE:CNK – Free Report).
Receive News & Ratings for Cinemark Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cinemark and related companies with MarketBeat.com's FREE daily email newsletter.
You might be interested in:
Peloton Interactive, Inc. Shares Acquired by Russell Investments Group Ltd.
Cinemark Holdings, Inc. Shares Acquired by Russell Investments Group Ltd.
Russell Investments Group Ltd. Boosts Stake in Outlook Therapeutics, Inc.
Russell Investments Group Ltd. Sells 4,965 Shares of NextDecade Co.
Russell Investments Group Ltd. Buys 9,248 Shares of ADC Therapeutics SA
Russell Investments Group Ltd. Purchases 2,303 Shares of Gambling.com Group Limited